Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

686
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
686
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

769
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
769
Tissue Transplantation01:24

Tissue Transplantation

1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

563
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
563
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): A randomised controlled non-inferiority trial.

The Journal of infection·2025
Same author

How to Do Things With Words: Language Interventions to Improve Mentoring Effectiveness.

The chronicle of mentoring & coaching·2025
Same author

Helping mentors address scientific communication in STEM research training helps their mentees stay the course.

International journal of STEM education·2025
Same author

Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013.

Canadian journal of surgery. Journal canadien de chirurgie·2025
Same author

Economic evaluation of the "paramedics and palliative care: bringing vital services to Canadians" program compared to the status quo.

CJEM·2024
Same author

Comparison of recovery of sheep, goats, and calves from reversible electrical head-only and head-to-body stunning for halal meat production.

New Zealand veterinary journal·2024

Related Experiment Video

Updated: Mar 28, 2026

A Modified Method for Heterotopic Mouse Heart Transplantion
11:29

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 23, 2014

13.4K

Relationship Between Hyperglycemia and Heart Transplant Rejection.

R Mateo1, S Gupta1, A Wallia1

  • 1Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Transplantation Proceedings
|December 19, 2015
PubMed
Summary

Poor glycemic control after heart transplant may increase rejection risk. While not statistically significant, higher glucose levels trended with higher rejection grades, suggesting a potential link.

More Related Videos

Intraportal Transplantation of Pancreatic Islets in Mouse Model
09:01

Intraportal Transplantation of Pancreatic Islets in Mouse Model

Published on: May 5, 2018

10.4K
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
10:43

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Published on: October 31, 2007

29.4K

Related Experiment Videos

Last Updated: Mar 28, 2026

A Modified Method for Heterotopic Mouse Heart Transplantion
11:29

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 23, 2014

13.4K
Intraportal Transplantation of Pancreatic Islets in Mouse Model
09:01

Intraportal Transplantation of Pancreatic Islets in Mouse Model

Published on: May 5, 2018

10.4K
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
10:43

Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice

Published on: October 31, 2007

29.4K

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Endocrinology

Background:

  • Hyperglycemia is a known risk factor for kidney and liver transplant rejection.
  • The impact of glycemic control on heart transplant rejection remains less understood.
  • Effective post-transplant management is crucial for long-term graft survival.

Purpose of the Study:

  • To investigate the association between perioperative and subsequent glycemic control and heart transplant rejection.
  • To analyze rejection rates in heart transplant patients over one year post-transplantation.
  • To identify factors influencing the risk of heart transplant rejection.

Main Methods:

  • Retrospective analysis of 157 heart transplant patients from June 2005 to December 2012.
  • Analysis of perioperative glucose levels and comparison between patients with and without rejection.
  • Rejection assessment based on routine follow-up biopsy specimens (grade ≤1R vs. ≥2R).

Main Results:

  • No significant difference in preoperative or inpatient glucose levels between rejection groups.
  • Mean glucose levels from discharge to 1 year trended higher in the higher rejection grade group (≥2R) (142.2 ± 46.6 mg/dL vs. 128.8 ± 40.9 mg/dL, P = .084).
  • Older age and higher BMI were associated with lower odds of developing grade ≥2R rejection.

Conclusions:

  • The trend between glucose levels and heart transplant rejection was not statistically significant.
  • The possibility that significantly higher glucose levels could influence rejection rates cannot be excluded.
  • Further research is needed to clarify the role of glycemic control in heart transplant outcomes.